These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27842789)

  • 1. Ketamine: A Cause of Urinary Tract Dysfunction.
    Myers FA; Bluth MH; Cheung WW
    Clin Lab Med; 2016 Dec; 36(4):721-744. PubMed ID: 27842789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gourd-shaped bladder associated with ketamine abuse.
    Wei Y; Yang J; Song W; Guo Q
    Urol Int; 2012; 89(1):123-4. PubMed ID: 22710405
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Ketamine Cystitis: Practical Considerations in Management.
    Schaeffer EM
    J Urol; 2016 Feb; 195(2):370. PubMed ID: 26852983
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete reversal of the clinical symptoms and image morphology of ketamine cystitis after intravesical hyaluronic acid instillation: A case report.
    Ou YL; Liu CY; Cha TL; Wu ST; Tsao CW
    Medicine (Baltimore); 2018 Jul; 97(28):e11500. PubMed ID: 29995815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bladder pain and urinary tract symptoms as a consequence of ketamine abuse].
    Reinhardt S; Fode M
    Ugeskr Laeger; 2014 Feb; 176(3):240-2. PubMed ID: 24629752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ketamine-induced urinary symptoms].
    Reinhardt S; Fode M
    Ugeskr Laeger; 2014 Feb; 176(3):243-4. PubMed ID: 24629753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit ketamine and its bladder consequences: is it irreversible?
    Jalil R; Gupta S
    BMJ Case Rep; 2012 Oct; 2012():. PubMed ID: 23112264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ketamine-induced vesicopathy].
    Lieb M; Bader M; Palm U; Stief CG; Baghai TC
    Psychiatr Prax; 2012 Jan; 39(1):43-5. PubMed ID: 22234442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What urologists need to know about ketamine-induced uropathy: A systematic review.
    Castellani D; Pirola GM; Gubbiotti M; Rubilotta E; Gudaru K; Gregori A; Dellabella M
    Neurourol Urodyn; 2020 Apr; 39(4):1049-1062. PubMed ID: 32212278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine cystitis: practical considerations in management.
    Misra S; Chetwood A; Coker C; Thomas P
    Scand J Urol; 2014 Oct; 48(5):482-8. PubMed ID: 24779452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine-associated vesicopathy.
    Chen YC; Chen YL; Huang GS; Wu CJ
    QJM; 2012 Oct; 105(10):1023-4. PubMed ID: 21920995
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.
    Yek J; Sundaram P; Aydin H; Kuo T; Ng LG
    Singapore Med J; 2015 Dec; 56(12):660-4; quiz 665. PubMed ID: 26702160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.
    Lai Y; Wu S; Ni L; Chen Z; Li X; Yang S; Gui Y; Guan Z; Cai Z; Ye J
    Urol Int; 2012; 89(1):93-6. PubMed ID: 22710265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine-induced vesicopathy: a literature review.
    Middela S; Pearce I
    Int J Clin Pract; 2011 Jan; 65(1):27-30. PubMed ID: 21155941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced functional bladder capacity associated with ketamine use.
    Ramos SP; Zambonato TK; Graziottin TM
    Braz J Psychiatry; 2019; 41(3):270-271. PubMed ID: 31189007
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk Factors of Lower Urinary Tract Syndrome among Ketamine Users.
    Chen IC; Lee MH; Chen WC; Hu TC; Lin HY
    Low Urin Tract Symptoms; 2018 Sep; 10(3):281-286. PubMed ID: 28707385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcerative cystitis associated with ketamine.
    Tsai JH; Tsai KB; Jang MY
    Am J Addict; 2008; 17(5):453. PubMed ID: 18770091
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketamine bladder syndrome: an important differential diagnosis when assessing a patient with persistent lower urinary tract symptoms.
    Srirangam S; Mercer J
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23035160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics for different therapeutic strategies in the management ketamine cystitis.
    Jhang JF; Birder LA; Chancellor MB; Kuo HC
    Neurourol Urodyn; 2017 Mar; 36(3):687-691. PubMed ID: 26998599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.
    Wang J; Chen Y; Gu D; Zhang G; Chen J; Zhao J; Wu P
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F961-F972. PubMed ID: 28331066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.